HLB Panagene046210

Largest holderHLB8.44%$3.1M

Filed holders145% or more, plus insiders

Price and institutional trades

1Y 2Y

$0.79−37.8%1Y

DecJanFebMarAprMayJunJulAugSepOctNov

Holders

$3.6M · direct 8.44% · indirect 1.46% · 2026-08-279.90%

Direct8.44%
HLB Therapeutics 13.64% → HLB bioStep 1.84% → HLB Panagene 7.14%0.02%
HLB bioStep 14.51% → HLB Panagene 7.14%1.04%
HLB Therapeutics 13.64% → HLB Panagene 1.30%0.18%
HLB innoVation 16.07% → HLB Panagene 1.30%0.21%
HLB Life Science 16.81% → HLB innoVation 7.89% → HLB Panagene 1.30%0.02%

$2.6M · direct 7.14% · indirect 0.03% · 2026-08-277.17%

Direct7.14%
HLB innoVation 2.02% → HLB Panagene 1.30%0.03%

$2.1M · 2026-08-135.71%

$1.7M · 2025-08-264.87%

$751K · direct 1.30% · indirect 0.78% · 2026-08-272.08%+0.41pp

Direct1.30%

Companies held by HLB Panagene

HLB Genex$3.4M · 2026-10-156.24%HLB Pep$1.3M · 2026-08-204.20%HLB Therapeutics$569K · 2026-10-210.33%

Filings

Filed	Changed	Before → after	Amount	Avg buy price
2026-08-27	-	1.01 → 1.30%	+$115K	-	Filing
2026-08-27	2026-08-20	20.53 → 20.82%	+$115K	$0.88	Filing
2026-08-13	2026-08-03	6.33 → 6.38%	+$40K	$0.94	Filing
2026-07-29	-	0.89 → 1.01%	+$46K	-	Filing
2026-07-22	2026-07-21	20.40 → 20.53%	+$48K

HLB 7.15% → HLB bioStep 14.51% → HLB Panagene 7.14%0.07%

HLB bioStep 0.98% → HLB Panagene 7.14%0.07%

HLB 7.15% → HLB Therapeutics 13.64% → HLB Panagene 1.30%0.01%

HLB 7.15% → HLB Panagene 8.44%0.60%

HLB 7.15% → HLB innoVation 16.07% → HLB Panagene 1.30%0.01%

HLB Therapeutics$517K · direct 1.30% · indirect 0.13% · 2026-08-271.43%

Direct1.30%
HLB bioStep 1.84% → HLB Panagene 7.14%0.13%

HLB innoVation$469K · 2026-08-271.30%

HLB Investment$469K · 2026-08-271.30%

6 other related parties$295K0.82%

Average cost is the mean purchase price from filings since November 2024. Indirect stakes multiply ownership through listed companies.

Indirect-only holders

Samsung Asset Management$140K · indirect0.39%

HLB 4.09% → HLB bioStep 14.51% → HLB Panagene 7.14%0.04%
HLB 4.09% → HLB Panagene 8.44%0.35%

BlackRock$107K · indirect0.30%

HLB 1.69% → HLB bioStep 14.51% → HLB Panagene 7.14%0.02%
HLB 1.69% → HLB Panagene 8.44%0.14%
HLB 0.96% → HLB Panagene 8.44%0.08%
HLB 0.51% → HLB Panagene 8.44%0.04%
HLB 0.14% → HLB Panagene 8.44%0.01%

HLB Pharmaceutical$43K · indirect0.12%

HLB Therapeutics 1.28% → HLB Panagene 1.30%0.02%
HLB innoVation 7.84% → HLB Panagene 1.30%0.10%

HLB Life Science$42K · indirect0.12%

HLB Pharmaceutical 14.05% → HLB innoVation 7.84% → HLB Panagene 1.30%0.01%
HLB innoVation 7.89% → HLB Panagene 1.30%0.10%

$40K · indirect0.11%

HLB 1.17% → HLB bioStep 14.51% → HLB Panagene 7.14%0.01%
HLB 1.17% → HLB Panagene 8.44%0.10%

No direct stake in the filings. It may be under 5% or filed before November 2024, so actual holdings may be larger.

Show 1 unchanged reports

Filed	Changed	Holder	Change	Before → after	Amount	Avg buy price
2026-06-18	2026-06-12	HLB	No change	20.39 → 20.39%	+$1,558	$1.02	Filing

20 in the last 2 years · amount = quantity × price per trade in the last year (closing price where no price is filed), avg buy price = average of buys in that filing · change dates and prices only where the original filing was fetched

· avg $0.80 (partial)

Jin Yang-gonInsider report